Delivery Order SPE2DB22D3301-SPE2DB24FY9TA

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $23,188.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin products, which are used for diabetes management. The contract type is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 16, 2023. This award is not designated as a set-aside, indicating...
This federal contract award, valued at $2,076.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical supply product, with a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $17,126.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was made by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,772.86 firm-fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a type of insulin medication. The contract has no set-aside designation and is being performed in Conshohocken, PA. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for TRESIBA FLEXTOUCH 100 UNIT/ML 3ML. The contract has a firm fixed price of $2,782.23 and a completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.53, is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medication used for diabetes management. The contract is a delivery order with a firm fixed price, and has a performance period through December 24, 2024. This contract award is not designated as a set-aside, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,410.78, is for the delivery of Tresiba FlexTouch insulin products. It is a firm-fixed-price delivery order contract with a completion date of December 20, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award, valued at $45,870.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes management medication. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $36,069.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medical product, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,315.08 firm fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML insulin syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9TA
    Delivery Order

This federal contract award, valued at $16,785.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML medical supplies, a type of insulin delivery device. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience in supplying a wide range of pharmaceutical products and medical supplies to federal healthcare programs, particularly within the military and veterans' healthcare systems, makes them a key vendor for the DLA.

Generated 5/17/25, 10:13 AM